A new clinical trial from noted pediatric neurologist Dr. Carlos G. Aguirre-Velazquez has found CBD oil to be effective for seizures. The study, just published in the Journal of Advances in Medicine and Medical Research, investigated the efficacy of CBD oil for seizures associated with tuberous sclerosis complex (TSC), an incurable genetic disorder characterized by the growth of benign tumors throughout the body, including the brain.
The leading cause of epilepsy and autism, TSC affects 1 in 6,000 people. The growth of tumors, despite being noncancerous, can lead to convulsive conditions and additional significant health problems when they impose on major organs. TSC-associated seizures in children can cause developmental and learning issues.
In the study, Aguirre measured whether CBD oil had an effect on seizure frequency, intensity, and duration in those with varying forms of epilepsy, with the majority of the trial’s participants made up of TSC patients who experienced related convulsive crises. Cannabidiol (CBD) oil is a non-psychoactive oil extracted from the stalks, seeds and flowers of cannabis plants like hemp.
Aguirre’s study found that 60 percent of participants who used CBD products experienced a significant reduction (80 percent – 100 percent) in seizure frequency.
“The experience of parents and patients with medicinal cannabis (CBD), as reported in our survey, suggests that CBD reduced the frequency, intensity, and duration of convulsive crises secondary to TSC,” Aguirre concluded in the study. “Additionally, the reports indicate that there was improvement in other clinical symptoms.”
The study also found CBD had substantial positive effects on qualify of life metrics, including mood, appetite, and cognition. Additionally, CBD caused a significant reduction in total treatment costs by reducing the need for other conventional pharmaceuticals. No serious side effects were reported.
This study’s findings add to a growing body of evidence that CBD may be effective for managing seizure activity, suggesting that CBD oil could be beneficial for the around 85 percent of people with TSC who have seizure symptoms. There are an estimated 1 million people worldwide with TSC, and 50,000 people in the U.S. alone.
You can learn even more about CBD and its potential therapeutic properties for seizure disorders by visiting our education page.
You may also be interested in these related articles:
- Study Looks at Why and How Parents Choose Cannabinoids for Their Kids with Epilepsy
- Seizures in Children: Types of Disorders and How CBD May Help
- American Epilepsy Society Study Finds CBD Effective for Reducing Seizure Frequency
- CBD Demonstrates Efficacy for Reducing Seizures in Children in First Clinical Trial